What is AGY.L's gross margin?

Allergy (AGY.L) has a gross margin of 53% and a net margin of -55%.

What is AGY.L's P/E ratio?

Track Allergy (AGY.L) P/E ratio, ROE, and valuation metrics over time.

Where can I see AGY.L's full financials?

See Allergy (AGY.L) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Allergy (AGY.L) Financials — Revenue, Earnings, Cash Flow

Also trades as: AGYTF (OTC) · $vol 0M

£5.00 ($0.07)

+0.24 (+5.04%)

Weekly Expected Move ±8.3%

£4 £4 £5 £5 £6

LSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 35 · £300.8M mcap · 745M float · 0.056% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers

📊 Key Metrics

TTM

£113M

Revenue

-3.7% YoY

£-85M

Net Income

-6.9% YoY

£-70M

Free Cash Flow

-3.1% YoY

53.3%

Gross Margin

-32.9%

Op. Margin

-54.9%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-551.0%

ROA-120.8%

ROIC-244.2%

Valuation

P/E-4.8

P/B58.4

EV/EBITDA-9.8

Leverage

Debt/Equity6.30

Current Ratio1.13

Interest Cov.-5.8x

Quality Scores

Piotroski F1/9

Altman Z-0.59

Beneish M-3.85